The DOI matches its Crossref record; 314 of the 314 references it cites were found in a registry or an index.
The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors—A Review of Literature
Open accessAbstract
Hypoxia is an integral component of the tumor microenvironment. Either as chronic or cycling hypoxia, it exerts a similar effect on cancer processes by activating hypoxia-inducible factor-1 (HIF-1) and nuclear factor (NF-κB), with cycling hypoxia showing a stronger proinflammatory influence. One of the systems affected by hypoxia is the CXC chemokine system. This paper reviews all available information on hypoxia-induced changes in the expression of all CXC chemokines (CXCL1, CXCL2, CXCL3, CXCL4, CXCL5, CXCL6, CXCL7, CXCL8 (IL-8), CXCL9, CXCL10, CXCL11, CXCL12 (SDF-1), CXCL13, CXCL14, CXCL15, CXCL16, CXCL17) as well as CXC chemokine receptors—CXCR1, CXCR2, CXCR3, CXCR4, CXCR5, CXCR6, CXCR7 and CXCR8. First, we present basic information on the effect of these chemoattractant cytokines on cancer processes. We then discuss the effect of hypoxia-induced changes on CXC chemokine expression on the angiogenesis, lymphangiogenesis and recruitment of various cells to the tumor niche, including myeloid-derived suppressor cells (MDSCs), tumor-associated macrophages (TAMs), tumor-associated neutrophils (TANs), regulatory T cells (Tregs) and tumor-infiltrating lymphocytes (TILs). Finally, the review summarizes data on the use of drugs targeting the CXC chemokine system in cancer therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–314 of 314
Vandyke, K., Zeissig, M. N., Hewett, D. R., Martin, S. K., Mrozik, K. M., Cheong, C. M., Diamond, P., To, L. B., Gronthos, S., Peet, D. J., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0115 · Cited by 64
Huang, G., Tao, L., Shen, S., & Chen, L. (2016) · Scientific Reports · doi:10.1038/srep27152 · Cited by 63
Marotta, D. E., Karar, J., Jenkins, W. T., Kumanova, M., Jenkins, K. W., Tobias, J. W., Baldwin, D. A., Hatzigeorgiou, A. G., Alexiou, P., Evans, S. M., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3061 · Cited by 62
HIF-1α promotes the migration and invasion of hepatocellular carcinoma cells via the IL-8–NF-κB axis
Feng, W., Xue, T., Huang, S., Shi, Q., Tang, C., Cui, G., Yang, G., Gong, H., & Guo, H. (2018) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-018-0077-1 · Cited by 62
Hsiao, K., Chang, N., Lin, S., Li, Y.-H., & Wu, M. (2014) · Human Reproduction · doi:10.1093/humrep/deu255 · Cited by 60
Molecular Pathways of Spontaneous and TNF-α–Mediated Neutrophil Apoptosis under Intermittent Hypoxia
Dyugovskaya, L., Polyakov, A., Ginsberg, D., Lavie, P., & Lavie, L. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0025oc · Cited by 60
Song, D., Fang, G., Mao, S., Ye, X., Liu, G., Miller, E. J., Greenberg, H. E., & Liu, S. F. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.01.027 · Cited by 60
Valsecchi, R., Coltella, N., Belloni, D., Ponente, M., ten Hacken, E., Scielzo, C., Scarfò, L., Bertilaccio, M. T. S., Brambilla, P., Lenti, E., et al. (2016) · Blood · doi:10.1182/blood-2015-07-657056 · Cited by 59
Miller, F., Kentsis, A., Osman, R., & Pan, Z. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m413160200 · Cited by 58
CXCR7 is induced by hypoxia and mediates glioma cell migration towards SDF-1α
Esencay, M., Sarfraz, Y., & Zagzag, D. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-347 · Cited by 57
Quintero, M., Gonzalez-Martin, M. D. C., Vega‐Agapito, V., González, C., Obeso, A., Farré, R., Agapito, T., & Yubero, S. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.08.180 · Cited by 57
Ronkainen, V., Tuomainen, T., Huusko, J., Laidinen, S., Malinen, M., Palvimo, J. J., Ylä‐Herttuala, S., Vuolteenaho, O. J., & Tavi, P. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt226 · Cited by 57
Pennathur-Das, R., & Levitt, L. (1987) · Blood · doi:10.1182/blood.v69.3.899.899 · Cited by 57
Deng, S., Deng, Q., Zhang, Y., Ye, H., Yu, X., Zhang, Y., Han, G. Y., Luo, P., Wu, M., Yu, Y., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.11.017 · Cited by 57
Dufies, M., Grytsai, O., Ronco, C., Oumar, C., Ambrosetti, D., Hagege, A., Parola, J., Mateo, L., Ayrault, M., Giuliano, S., et al. (2019) · Theranostics · doi:10.7150/thno.34681 · Cited by 57
Hongo, K., Tsuno, N. H., Kawai, K., Sasaki, K., Kaneko, M., Hiyoshi, M., Murono, K., Tada, N., Nirei, T., Sunami, E., et al. (2012) · Journal of Surgical Research · doi:10.1016/j.jss.2012.08.034 · Cited by 56
HIF2α is involved in the expansion of CXCR4-positive cancer stem-like cells in renal cell carcinoma
Micucci, C., Matacchione, G., Valli, D., Orciari, S., & Catalano, A. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.338 · Cited by 56
Chen, X., Takemoto, Y., Deng, H., Middelhoff, M. A., Friedman, R. A., Chu, T. H., Churchill, M., Ma, Y., Nagar, K. K., Tailor, Y. H., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1290034 · Cited by 56
Zhou, K., Xie, L. H., Peng, X., Guo, Q., Wu, Q., Wang, W. H., Zhang, G. L., Wu, J., Zhang, G. J., & Du, C. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.009 · Cited by 56
Glynn, P. C., Henney, E., & Hall, I. P. (2002) · Pulmonary Pharmacology & Therapeutics · doi:10.1006/pupt.2001.0323 · Cited by 55
Yu, X., Zhao, R., Lin, S., Bai, X., Zhang, L., Yuan, S., & Sun, L. (2015) · Oncology Reports · doi:10.3892/or.2015.4520 · Cited by 54
Hong, L., Wang, S., Li, W., Wu, D., & Chen, W. (2018) · Pathology - Research and Practice · doi:10.1016/j.prp.2018.07.009 · Cited by 54
Olbryt, M., Habryka, A., Student, S., Jarząb, M., Tyszkiewicz, T., & Lisowska, K. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105104 · Cited by 53
Wang, E., Zhang, C., Polavaram, N. S., Liu, F., Wu, G., Schroeder, M. A., Lau, J. S., Mukhopadhyay, D., Jiang, S., O’Neill, B. P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086102 · Cited by 53
Hepatocyte growth factor enhances CXCR4 expression favoring breast cancer cell invasiveness
Matteucci, E., Locati, M., & Desiderio, M. A. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.07.008 · Cited by 53
Expression of CXCL15 (Lungkine) in Murine Gastrointestinal, Urogenital, and Endocrine Organs
Schmitz, J., McCracken, V. J., Dimmitt, R. A., & Lorenz, R. G. (2007) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.6a7121.2007 · Cited by 53
Kasashima, H., Yashiro, M., Nakamae, H., Kitayama, K., Masuda, G., Kinoshita, H., Fukuoka, T., Hasegawa, T., Nakane, T., Hino, M., et al. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.07.024 · Cited by 53
CXCR6 and CCR5 Localize T Lymphocyte Subsets in Nasopharyngeal Carcinoma
Parsonage, G. N., Machado, L. R., Hui, J. W., McLarnon, A., Schmaler, T. T., Balasothy, M., To, K., Vlantis, A. C., van Hasselt, C. A., Lo, K. W., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.11.032 · Cited by 52
Tu, T. C., Nagano, M., Yamashita, T., Hamada, H., Ohneda, K., Kimura, K., & Ohneda, O. (2015) · Stem Cells and Development · doi:10.1089/scd.2015.0290 · Cited by 51
Gutsche, K., Randi, E. B., Blank, V., Fink, D. A., Wenger, R. H., Leo, C., & Scholz, C. C. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.10.002 · Cited by 51
Kee, J., Ito, A., Hojo, S., Hashimoto, I., Igarashi, Y., Tsukada, K., Irimura, T., Shibahara, N., Nakayama, T., Yoshie, O., et al. (2012) · Oncology Reports · doi:10.3892/or.2012.2185 · Cited by 50
Luo, Y., Azad, A. K., Karanika, S., Basourakos, S. P., Zuo, X., Wang, J., Yang, L., Yang, G., Korentzelos, D. K., Yin, J., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.31237 · Cited by 50
Chemokine C–X–C motif receptor 6 contributes to cell migration during hypoxia
Lin, S., Sun, L., Hu, J., Wan, S., Zhao, R., Yuan, S., & Zhang, L. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.01.029 · Cited by 49
Oh, Y. S., Kim, H. Y., Song, I., Yun, H., Jo, D., Kim, S., & Lee, H. J. (2012) · Oncology Reports · doi:10.3892/or.2012.2063 · Cited by 49
Huh, Y. H., Lee, G., Lee, K., Koh, J., Chun, J., & Ryu, J. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0816-x · Cited by 49
Xia, J., Liu, G.-H., Chen, Z.-Y., Mao, C., Zhou, D.-C., Wu, H.-Y., Park, K., Zhao, H., Kim, S., Cai, D., et al. (2016) · Cytokine · doi:10.1016/j.cyto.2016.02.007 · Cited by 49
Łoboda, A., Jaźwa, A., Józkowicz, A., Molema, G., & Dulak, J. (2006) · Vascular Pharmacology · doi:10.1016/j.vph.2005.11.007 · Cited by 48
Miyake, M., Furuya, H., Onishi, S., Hokutan, K., Anai, S., Chan, O. T. M., Shi, S., Fujimoto, K., Goodison, S., Cai, W., et al. (2019) · Theranostics · doi:10.7150/thno.29553 · Cited by 48
Tian, H., Huang, P., Zhao, Z., Tang, W., & Xia, J. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000366357 · Cited by 46
Wu, X., Sun, A., Yu, W., Hong, C., & Liu, Z. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.110866 · Cited by 46
Tumor stroma and chemokines control T-cell migration into melanoma following Temozolomide treatment
Tan, K. W., Evrard, M., Tham, M., Hong, M. L. W., Huang, C. W., Kato, M., Prévost‐Blondel, A., Donnadieu, E., Ng, L. G., & Abastado, J. (2015) · OncoImmunology · doi:10.4161/2162402x.2014.978709 · Cited by 45
HIF-1α induces immune escape of prostate cancer by regulating NCR1/NKp46 signaling through miR-224
Chen, C., Li, S.-X., Xiang, L., Mu, H., Wang, S.-B., & Yu, K.-Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.06.007 · Cited by 45
Voss, M. J., Möller, M. F., Powe, D. G., Niggemann, B., Zänker, K. S., & Entschladen, F. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-158 · Cited by 44
Hypoxia stimulates CXCR4 signalling in ileal carcinoids
Arvidsson, Y., Bergström, A., Arvidsson, L., Kristiansson, E., Ahlman, H., & Nilsson, O. (2010) · Endocrine Related Cancer · doi:10.1677/erc-09-0085 · Cited by 44
Guan, Z., Ding, C., Du, Y., Zhang, K., Zhu, J., Zhang, T., He, D., Xu, S., Wang, X., & Fan, J. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2210 · Cited by 43
Krawczyk, K. M., Nilsson, H., Allaoui, R., Lindgren, D., Arvidsson, M., Leandersson, K., & Johansson, M. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.78 · Cited by 43
The Chemokine CXCL13 (BCA-1) Inhibits FGF-2 Effects on Endothelial Cells
Spinetti, G., Camarda, G., Bernardini, G., Peppe, S. R. D., Capogrossi, M. C., & Napolitano, M. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5924 · Cited by 42
Noninvasive Imaging of Cycling Hypoxia in Head and Neck Cancer Using Intrinsic Susceptibility MRI
Panek, R., Welsh, L. C., Baker, L. C. J., Schmidt, M. A., Wong, K. H., Riddell, A. M., Koh, D., Dunlop, A., Mcquaid, D., d’Arcy, J. A., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1209 · Cited by 42
Involvement of HIF-1 in Invasion of Mum2B Uveal Melanoma Cells
Victor, N., Ivy, A., Jiang, B., & Agani, F. H. (2006) · Clinical & Experimental Metastasis · doi:10.1007/s10585-006-9024-z · Cited by 41
High-level expression of CXCR4 in breast cancer is associated with early distant and bone metastases
Hung, C., Su, H.-Y., Liang, H.-H., Lai, C., Chang, Y.-C., Ho, Y.-S., Wu, C., Ho, J.-D., Wei, P., & Chang, Y. (2013) · Tumor Biology · doi:10.1007/s13277-013-1218-9 · Cited by 41
The Association of CXCR3 and Renal Cell Carcinoma Metastasis
Utsumi, T., Suyama, T., Imamura, Y., Fuse, M., Sakamoto, S., Nihei, N., Ueda, T., Suzuki, H., Seki, N., & Ichikawa, T. (2014) · The Journal of Urology · doi:10.1016/j.juro.2014.01.100 · Cited by 40
Tellier, C., Desmet, D., Petit, L., Finet, L., Graux, C., Raes, M. J., Féron, O., & Michiels, C. (2015) · Neoplasia · doi:10.1016/j.neo.2014.11.003 · Cited by 40
Idorn, M., Olsen, M., Halldórsdóttir, H. R., Skadborg, S. K., Pedersen, M., Høgdall, C. K., Høgdall, E. V. S., Met, Ö., & Straten, P. T. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1412029 · Cited by 40
Hypoxia enhances indoleamine 2,3-dioxygenase production in dendritic cells
Song, X. H., Zhang, Y., Zhang, L., Song, W., & Shi, L. (2018) · Oncotarget · doi:10.18632/oncotarget.24098 · Cited by 40
Fei, M., Guan, J., Xue, T., Qin, L., Tang, C., Cui, G., Wang, Y., Gong, H., & Feng, W. (2018) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-018-0100-6 · Cited by 40
Transcriptional regulation of FoxM1 by HIF‑1α mediates hypoxia‑induced EMT in prostate cancer
Tang, C., Liu, T., Wang, K., Wang, X., Xu, S., He, D., & Zeng, J. (2019) · Oncology Reports · doi:10.3892/or.2019.7248 · Cited by 40
Sugita (2009) · International Journal of Oncology · doi:10.3892/ijo_00000192 · Cited by 39
Meng, L., Zhao, Y., Bu, W., Li, X., Liu, X., Zhou, D., Chen, Y., Zheng, S., Lin, Q., Liu, Q., et al. (2020) · Cell Proliferation · doi:10.1111/cpr.12859 · Cited by 39
Shin, D. H., Li, S. H., Yang, S., Lee, B. L., Lee, M. K., & Park, J. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07069.x · Cited by 38
CXCL14 is no direct modulator of CXCR4
Otte, M., Kliewer, A., Schütz, D., Reimann, C., Schulz, S., & Stumm, R. K. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.11.009 · Cited by 38
Ullah, K., Rosendahl, A.-H., Izzi, V., Bergmann, U., Pihlajaniemi, T. A., Mäki, J. M., & Myllyharju, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-17376-0 · Cited by 37
Expression and effect of CXCL14 in colorectal carcinoma
Lin, K., Zou, R., Lin, F., Zheng, S., Shen, X., & Xue, X. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2343 · Cited by 36
A New Anti-CXCR4 Antibody That Blocks the CXCR4/SDF-1 Axis and Mobilizes Effector Cells
Broussas, M., Boute, N., Akla, B., Berger, S., Beau‐Larvor, C., Champion, T., Robert, A., Beck, A., Haeuw, J., Goetsch, L., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0041 · Cited by 36
Kang, N., Choi, S. Y., Kim, B. N., Yeo, C. D., Park, C. K., Kim, Y. K., Kim, T. J., Lee, S., Lee, S. H., Park, J. Y., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-5360-7 · Cited by 36
Difference in proangiogenic potential of systemic and pulmonary endothelium: role of CXCR2
Moldobaeva, A., & Wagner, E. M. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00370.2004 · Cited by 35
Wang, L., Niu, Z., Wang, X., Li, Z., Liu, Y., Luo, F., & Yan, X. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117167 · Cited by 35
Wysoczynski, M., Shin, D., Kucia, M., & Ratajczak, M. Z. (2009) · International Journal of Cancer · doi:10.1002/ijc.24732 · Cited by 34
Aalinkeel, R., Nair, B. B., Chen, C., Mahajan, S. D., Reynolds, J. L., Zhang, H., Sun, H., Sykes, D. E., Chadha, K. C., Turowski, S. G., et al. (2016) · Immunology · doi:10.1111/imm.12618 · Cited by 34
STAT1 represses hypoxia-inducible factor-1-mediated transcription
Hiroi, M., Mori, K., Sakaeda, Y., Shimada, J., & Ohmori, Y. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.138 · Cited by 33
Lin, S., Hsiao, K., Chang, N., Hou, P., & Tsai, S. (2016) · The Journal of Pathology · doi:10.1002/path.4868 · Cited by 33
Effect of Hypoxic Stress on Migration and Characteristics of Monocytes in Uveal Melanoma
Bronkhorst, I. H. G., Jehs, T., Dijkgraaf, E. M., Luyten, G. P. M., van der Velden, P. A., van der Burg, S. H., & Jager, M. J. (2014) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2014.43 · Cited by 32
CXCR4 blockade with AMD3100 enhances Taxol chemotherapy to limit ovarian cancer cell growth
Reeves, P. M., Abbaslou, M. A., Kools, F. R. W., & Poznansky, M. C. (2017) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000518 · Cited by 32
Hypoxia Increases Thyroid Cancer Stem Cell‐Enriched Side Population
Mahkamova, K., Latar, N. H. M., Aspinall, S. R., & Meeson, A. P. (2017) · World Journal of Surgery · doi:10.1007/s00268-017-4331-x · Cited by 32
Fan, L., Zhu, Q., Liu, L., Zhu, C., Huang, H., Lu, S., & Liu, P. (2017) · Oncotarget · doi:10.18632/oncotarget.18387 · Cited by 31
Fu, S., Chen, X. '., Lin, H.-J. L., & Lin, J. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4389 · Cited by 31
Kinoshita, H., Yashiro, M., Fukuoka, T., Hasegawa, T., Morisaki, T., Kasashima, H., Masuda, G., Noda, S., & Hirakawa, K. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv134 · Cited by 30
NF-κB suppresses HIF-1α response by competing for P300 binding
Mendonça, D. B. S., Mendonça, G., Aragão, F. J. L., & Cooper, L. F. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.12.098 · Cited by 30
SB225002 inhibits prostate cancer invasion and attenuates the expression of BSP, OPN and MMP‑2
Xu, M., Jaing, H., Wang, H., Liu, J., Liu, B., & Guo, Z. (2018) · Oncology Reports · doi:10.3892/or.2018.6504 · Cited by 30
CXCL7-induced macrophage infiltration in lung tumor is independent of CXCR2 expression
Ünver, N., Esendağlı, G., Yılmaz, G., & Güç, D. (2015) · Cytokine · doi:10.1016/j.cyto.2015.07.018 · Cited by 29
VEGF expression is regulated by HIF‐1α and ARNT in 3D KYSE‐70, esophageal cancer cell spheroids
Terashima, J., Sampei, S., Iidzuka, M., Ohsakama, A., Tachikawa, C., Satoh, J., Kudo, K., Habano, W., & Ozawa, S. (2016) · Cell Biology International · doi:10.1002/cbin.10656 · Cited by 29
Tanegashima, K., Takahashi, R., Nuriya, H., Iwase, R., Naruse, N., Tsuji, K., Shigenaga, A., Otaka, A., & Hara, T. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.09.012 · Cited by 29
Kusuyama, J., Bandow, K., Ohnishi, T., Amir, M. S., Shima, K., Semba, I., & Matsuguchi, T. (2019) · Biochemical Journal · doi:10.1042/bcj20190709 · Cited by 29
Li, X., Zhao, L., & Meng, T. (2020) · Cell Biochemistry and Function · doi:10.1002/cbf.3516 · Cited by 29
Liu, L., Xie, F., Chang, K., Li, M., Meng, Y., Wang, X., Li, H., Li, D., & Yu, J. (2014) · Europe PMC (PubMed Central) · Cited by 28
Takahashi, R., Amano, H., Ito, Y., Eshima, K., Satoh, T., Iwamura, M., Nakamura, M., Kitasato, H., Uematsu, S., Raouf, J., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109581 · Cited by 28
Strickland, J. D., Garrison, D., & Copple, B. L. (2020) · Cytokine · doi:10.1016/j.cyto.2020.154986 · Cited by 28
Antitumor Effect of IP-10 by Using Two Different Approaches: Live Delivery System and Gene Therapy
Taslimi, Y., Zahedifard, F., Habibzadeh, S., Taheri, T., Abbaspour, H., Sadeghipour, A., Mohit, E., & Rafati, S. (2016) · Journal of Breast Cancer · doi:10.4048/jbc.2016.19.1.34 · Cited by 27
Spinello, I., Quaranta, M. T., Paolillo, R., Pelosi, E., Cerio, A., Saulle, E., Coco, F. L., Testa, U., & Labbaye, C. (2015) · Haematologica · doi:10.3324/haematol.2014.120295 · Cited by 26
Oriuchi, N., Aoki, M., Ukon, N., Washiyama, K., Tan, C., Shimoyama, S., Nishijima, K., Takahashi, K., Ito, H., Ikezoe, T., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-63557-9 · Cited by 26
Herwartz, C., Castillo-Juárez, P., Schröder, L., Barrón, B. L., & Steger, G. (2015) · Mediators of Inflammation · doi:10.1155/2015/804264 · Cited by 25
Expression and functional roles of the chemokine receptor CXCR7 in acute myeloid leukemia cells
Kim, H.-Y., Lee, S.-Y., Kim, D. Y., Moon, J.-Y., Choi, Y., Song, I., Lee, H. J., Yun, H., Kim, S., & Jo, D. (2015) · Blood Research · doi:10.5045/br.2015.50.4.218 · Cited by 25
Tip110/SART3 regulates IL-8 expression and predicts the clinical outcomes in melanoma
Timani, K. A., Győrffy, B., Liu, Y., Mohammad, K. S., & He, J. J. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0868-z · Cited by 25
New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer
D’Alterio, C., Zannetti, A., Trotta, A. M., Ieranò, C., Napolitano, M., Rea, G., Greco, A., Maiolino, P., Albanese, S., Scognamiglio, G., et al. (2020) · Cancers · doi:10.3390/cancers12071952 · Cited by 25
Hattermann, K., Bartsch, K., Gebhardt, H., Mehdorn, H. M., Synowitz, M., Schmitt, A. D., Mentlein, R., & Held‐Feindt, J. (2016) · Cell Communication and Signaling · doi:10.1186/s12964-016-0149-7 · Cited by 22
Identification of hypoxia-regulated angiogenic genes in colorectal cancer
Zong, S., Li, W., Li, H., Han, S., liu, S., Shi, Q., & Hou, F. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.08.169 · Cited by 22
Ni, X., Xing, Y., Sun, X., & Suo, J. (2019) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2019.05.007 · Cited by 22
Chiang, Y.-Y. (2009) · Molecular Carcinogenesis · doi:10.1002/mc.20521 · Cited by 21
Timani, K. A., Liu, Y., Fan, Y., Mohammad, K. S., & He, J. J. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00001-15 · Cited by 20
Chen, K., He, L., Li, Y., Li, X., Qiu, C., Pei, H., & Yang, D. (2020) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000819 · Cited by 19
Effect of chemokine CXCL14 on in vitro angiogenesis of human hepatocellular carcinoma cells
Liu, Y., Chang, Q., Wu, X., Yu, Y., & Zhang, H. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1769677 · Cited by 19
Zhang, M., Gao, C., Chen, W., Tang, Y., Nie, J., Shen, L., Ma, X., & Chen, D. (2017) · Oncology Letters · doi:10.3892/ol.2017.7636 · Cited by 17
Rat astrocytes during anoxia: Secretome profile of cytokines and chemokines
Samy, Z. A., Al-Abdullah, L., Turčáni, M., Craik, J. D., & Redzic, Z. B. (2018) · Brain and Behavior · doi:10.1002/brb3.1013 · Cited by 16
Regulation of IL-8RA (CXCR1) expression in polymorphonuclear leukocytes by hypoxia/reoxygenation
Grutkoski, P. S., Graeber, C. T., DʼAmico, R., Keeping, H. S., & Simms, H. H. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.65.2.171 · Cited by 11
Differential expression of cytokines and receptor expression during anoxic growth
Plotkin, B. J., Sigar, I. M., Swartzendruber, J. A., Kaminski, A., & Davis, J. W. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3520-5 · Cited by 11
Endler, A., Chen, L., Li, Q., Uchida, K., Hashimoto, T., Lü, L., Xu, G., & Shibasaki, F. (2013) · Cytokine · doi:10.1016/j.cyto.2013.01.021 · Cited by 10
Biological characteristics of prostate cancer cells are regulated by hypoxia-inducible factor 1α
Huang, X., Zhou, J., LIU, J., Tang, B., Zhao, F., & Qu, Y. (2014) · Oncology Letters · doi:10.3892/ol.2014.2259 · Cited by 10
CXCL14 Maintains hESC Self-Renewal through Binding to IGF-1R and Activation of the IGF-1R Pathway
Cheng, C., Yang, S.-C., Lai, C.-Y., Wang, C.-K., Chang, C., Lin, C.-Y., Chen, W., Lin, P.-Y., Wu, H., Ma, N. J.-L., et al. (2020) · Cells · doi:10.3390/cells9071706 · Cited by 10
New role of hypoxia in pathophysiology of multiple myeloma through miR-210
Saba, F., Soleimani, M., & Abroun, S. (2018) · EXCLI journal · doi:10.17179/excli2018-1109 · Cited by 9
Seo, Y., Koh, S. H., Kang, H. J., Shin, H. Y., Jeong, G., & Ahn, H. S. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.10.023 · Cited by 7
Konishi, H., Shirabe, K., Nakagawara, H., Harimoto, N., Yamashita, Y., Ikegami, T., Yoshizumi, T., Soejima, Y., Oda, Y., & Maehara, Y. (2015) · Cancer Science · doi:10.1111/cas.12653 · Cited by 7
Jamaludin, S. Y. N., Azimi, I., Davis, F. M., Peters, A. A., Gonda, T. J., Thompson, E. W., Roberts‐Thomson, S. J., & Monteith, G. R. (2018) · Oncology Letters · doi:10.3892/ol.2018.7827 · Cited by 7
Ligocki, A. J., & Niederkorn, J. Y. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-18786 · Cited by 6
Discordant mRNA and protein expression of CXCR4 under in vitro CoCl2-induced hypoxic conditions
Tang, M., Yang, Y., Yu, J., Wu, N., Chen, P., Xu, L., Wang, Q., Xu, Z., Ge, J., Yu, K., et al. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.01.102 · Cited by 5
Hypoxia–reoxygenation enhances interleukin-8 production from U937 human monocytic cells
Higashihara, H., Kokura, S., Imamoto, E., Ueda, M., Naito, Y., Yoshida, N., & Yoshikawa, T. (2004) · Redox Report · doi:10.1179/135100004225006894 · Cited by 3
Cited by
Macrophages at the interface of the co-evolving cancer ecosystem
Kloosterman, D. J., & Akkari, L. (2023) · Cell · doi:10.1016/j.cell.2023.02.020 · Cited by 427
Korbecki, J., Simińska, D., Gąssowska-Dobrowolska, M., Listos, J., Gutowska, I., Chlubek, D., & Baranowska-Bosiacka, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910701 · Cited by 380
Self-citationThe role of VEGF in cancer-induced angiogenesis and research progress of drugs targeting VEGF
Ghalehbandi, S., Yuzugulen, J., Pranjol, M. Z. I., & Pourgholami, M. H. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175586 · Cited by 362
Metadata
- Authors
- Korbecki, J., Kojder, K., Kapczuk, P., Kupnicka, P., Gawrońska-Szklarz, B., Gutowska, I., Chlubek, D., & Baranowska-Bosiacka, I.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-01-15
- Volume
- 22
- Issue
- 2
- Pages
- 843
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3118518279
- Cited by
- 273
- References
- 314
- FWCI
- 13.78
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.